<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T08:25:24Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9806455" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9806455</identifier>
        <datestamp>2023-01-03</datestamp>
        <setSpec>sageopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Int J Stroke</journal-id>
              <journal-id journal-id-type="iso-abbrev">Int J Stroke</journal-id>
              <journal-id journal-id-type="publisher-id">WSO</journal-id>
              <journal-id journal-id-type="hwp">spwso</journal-id>
              <journal-title-group>
                <journal-title>International Journal of Stroke</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1747-4930</issn>
              <issn pub-type="epub">1747-4949</issn>
              <publisher>
                <publisher-name>SAGE Publications</publisher-name>
                <publisher-loc>Sage UK: London, England</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9806455</article-id>
              <article-id pub-id-type="pmcid">PMC9806455</article-id>
              <article-id pub-id-type="pmc-uid">9806455</article-id>
              <article-id pub-id-type="pmid">36129364</article-id>
              <article-id pub-id-type="pmid">36129364</article-id>
              <article-id pub-id-type="doi">10.1177/17474930221129982</article-id>
              <article-id pub-id-type="publisher-id">10.1177_17474930221129982</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Protocol</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Implementation of increased physical therapy intensity for improving
walking after stroke: Walk ’n watch protocol for a multisite stepped-wedge
cluster-randomized controlled trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Peters</surname>
                    <given-names>Sue</given-names>
                  </name>
                  <xref rid="aff1-17474930221129982" ref-type="aff">1</xref>
                  <xref rid="aff2-17474930221129982" ref-type="aff">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lim</surname>
                    <given-names>Shannon B</given-names>
                  </name>
                  <xref rid="aff2-17474930221129982" ref-type="aff">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7860-9463</contrib-id>
                  <name>
                    <surname>Bayley</surname>
                    <given-names>Mark T</given-names>
                  </name>
                  <xref rid="aff3-17474930221129982" ref-type="aff">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Best</surname>
                    <given-names>Krista</given-names>
                  </name>
                  <xref rid="aff4-17474930221129982" ref-type="aff">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Connell</surname>
                    <given-names>Louise A</given-names>
                  </name>
                  <xref rid="aff5-17474930221129982" ref-type="aff">5</xref>
                  <xref rid="aff6-17474930221129982" ref-type="aff">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Corriveau</surname>
                    <given-names>Hélène</given-names>
                  </name>
                  <xref rid="aff7-17474930221129982" ref-type="aff">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Donkers</surname>
                    <given-names>Sarah J</given-names>
                  </name>
                  <xref rid="aff8-17474930221129982" ref-type="aff">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dukelow</surname>
                    <given-names>Sean P</given-names>
                  </name>
                  <xref rid="aff9-17474930221129982" ref-type="aff">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Klassen</surname>
                    <given-names>Tara D</given-names>
                  </name>
                  <xref rid="aff2-17474930221129982" ref-type="aff">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Milot</surname>
                    <given-names>Marie-Hélène</given-names>
                  </name>
                  <xref rid="aff7-17474930221129982" ref-type="aff">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sakakibara</surname>
                    <given-names>Brodie M</given-names>
                  </name>
                  <xref rid="aff10-17474930221129982" ref-type="aff">10</xref>
                  <xref rid="aff11-17474930221129982" ref-type="aff">11</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sheehy</surname>
                    <given-names>Lisa</given-names>
                  </name>
                  <xref rid="aff12-17474930221129982" ref-type="aff">12</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wong</surname>
                    <given-names>Hubert</given-names>
                  </name>
                  <xref rid="aff13-17474930221129982" ref-type="aff">13</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Yao</surname>
                    <given-names>Jennifer</given-names>
                  </name>
                  <xref rid="aff14-17474930221129982" ref-type="aff">14</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2093-0788</contrib-id>
                  <name>
                    <surname>Eng</surname>
                    <given-names>Janice J</given-names>
                  </name>
                  <xref rid="aff2-17474930221129982" ref-type="aff">2</xref>
                  <xref rid="corresp1-17474930221129982" ref-type="corresp"/>
                </contrib>
              </contrib-group>
              <aff id="aff1-17474930221129982"><label>1</label>School of Physical Therapy, University
of Western Ontario, London, ON, Canada</aff>
              <aff id="aff2-17474930221129982"><label>2</label>Rehabilitation Research Program, G.F.
Strong Rehabilitation Centre and Department of Physical Therapy, University of
British Columbia, Vancouver, BC, Canada</aff>
              <aff id="aff3-17474930221129982"><label>3</label>Division of Physical Medicine and
Rehabilitation, University of Toronto and KITE Research Institute University Health
Network, Toronto, ON, Canada</aff>
              <aff id="aff4-17474930221129982"><label>4</label>Intégré Universitaire de Santé et de
Services Sociaux de La Capitale-Nationale and Department of Rehabilitation,
Université Laval, Quebec, QC, Canada</aff>
              <aff id="aff5-17474930221129982"><label>5</label>Allied Health Research Unit, University
of Central Lancashire, Preston, UK</aff>
              <aff id="aff6-17474930221129982"><label>6</label>Rakehead Rehabilitation Centre, Burnley
General Teaching Hospital, East Lancashire Hospitals NHS Trust, Burnley, UK</aff>
              <aff id="aff7-17474930221129982"><label>7</label>School of Rehabilitation, Faculté de
médecine et des sciences de la santé and Research Center on Aging, Université de
Sherbrooke, Sherbrooke, QC, Canada</aff>
              <aff id="aff8-17474930221129982"><label>8</label>School of Rehabilitation Science,
College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada</aff>
              <aff id="aff9-17474930221129982"><label>9</label>Department of Clinical Neurosciences,
University of Calgary, Calgary, AB, Canada</aff>
              <aff id="aff10-17474930221129982"><label>10</label>Department of Occupational Science
and Occupational Therapy, University of British Columbia, Vancouver, BC,
Canada</aff>
              <aff id="aff11-17474930221129982"><label>11</label>Centre for Chronic Disease Prevention
and Management, University of British Columbia, Kelowna, BC, Canada</aff>
              <aff id="aff12-17474930221129982"><label>12</label>Bruyère Research Institute, Ottawa,
ON, Canada</aff>
              <aff id="aff13-17474930221129982"><label>13</label>School of Population and Public
Health, University of British Columbia and Centre for Health Evaluation &amp;
Outcomes Sciences, St. Paul’s Hospital, Vancouver, BC, Canada</aff>
              <aff id="aff14-17474930221129982"><label>14</label>Division of Physical Medicine and
Rehabilitation, University of British Columbia and G.F. Strong Rehabilitation
Centre, Vancouver, BC, Canada</aff>
              <author-notes>
                <corresp id="corresp1-17474930221129982">Janice J Eng, Rehabilitation Research
Program, G.F. Strong Rehabilitation Centre and Department of Physical Therapy,
University of British Columbia, 212-2177 Wesbrook Mall, Vancouver, BC V6T 1Z3,
Canada. Email: <email>Janice.eng@ubc.ca</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>28</day>
                <month>10</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>1</month>
                <year>2023</year>
              </pub-date>
              <volume>18</volume>
              <issue>1</issue>
              <fpage>117</fpage>
              <lpage>122</lpage>
              <history>
                <date date-type="received">
                  <day>15</day>
                  <month>5</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>5</day>
                  <month>9</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2022 World Stroke Organization</copyright-statement>
                <copyright-year>2022</copyright-year>
                <copyright-holder content-type="society">World Stroke
Organization</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
                  <license-p>This article is distributed under the terms of the Creative Commons
Attribution-NonCommercial 4.0 License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which
permits non-commercial use, reproduction and distribution of the work
without further permission provided the original work is attributed as
specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <sec id="section1-17474930221129982">
                  <title>Rationale:</title>
                  <p>Clinical practice guidelines support structured, progressive protocols for
improving walking after stroke. Yet, practice is slow to change, evidenced
by the little amount of walking activity in stroke rehabilitation units. Our
recent study (n = 75) found that a structured, progressive protocol
integrated with typical daily physical therapy improved walking and
quality-of-life measures over usual care. Research therapists progressed the
intensity of exercise by using heart rate and step counters worn by the
participants with stroke during therapy. To have the greatest impact, our
next step is to undertake an implementation trial to change practice across
stroke units where we enable the entire unit to use the protocol as part of
standard of care.</p>
                </sec>
                <sec id="section2-17474930221129982">
                  <title>Aims:</title>
                  <p>What is the effect of introducing structured, progressive exercise (termed
the Walk ’n Watch protocol) to the standard of care on the primary outcome
of walking in adult participants with stroke over the hospital inpatient
rehabilitation period? Secondary outcomes will be evaluated and include
quality of life.</p>
                </sec>
                <sec id="section3-17474930221129982">
                  <title>Methods and sample size estimates:</title>
                  <p>This national, multisite clinical trial will randomize 12 sites using a
stepped-wedge design where each site will be randomized to deliver Usual
Care initially for 4, 8, 12, or 16 months (three sites for each duration).
Then, each site will switch to the Walk ’n Watch phase for the remaining
duration of a total 20-month enrolment period. Each participant will be
exposed to either Usual Care or Walk ’n Watch. The trial will enroll a total
of 195 participants with stroke to achieve a power of 80% with a Type I
error rate of 5%, allowing for 20% dropout. Participants will be medically
stable adults post-stroke and able to take five steps with a maximum
physical assistance from one therapist. The Walk ’n Watch protocol focuses
on completing a minimum of 30 min of weight-bearing, walking-related
activities (at the physical therapists’ discretion) that progressively
increase in intensity informed by activity trackers measuring heart rate and
step number.</p>
                </sec>
                <sec id="section4-17474930221129982">
                  <title>Study outcome(s):</title>
                  <p>The primary outcome will be the change in walking endurance, measured by the
6-Minute Walk Test, from baseline (T1) to 4 weeks (T2). This change will be
compared across Usual Care and Walk ’n Watch phases using a linear
mixed-effects model. Additional physical, cognitive, and quality of life
outcomes will be measured at T1, T2, and 12 months post-stroke (T3) by a
blinded assessor.</p>
                </sec>
                <sec id="section5-17474930221129982">
                  <title>Discussion:</title>
                  <p>The implementation of stepped-wedge cluster-randomized trial enables the
protocol to be tested under real-world conditions, involving all clinicians
on the unit. It will result in all sites and all clinicians on the unit to
gain expertise in protocol delivery. Hence, a deliberate outcome of the
trial is facilitating changes in best practice to improve outcomes for
participants with stroke in the trial and for the many participants with
stroke admitted after the trial ends.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>Rehabilitation</kwd>
                <kwd>gait</kwd>
                <kwd>outcomes</kwd>
                <kwd>stroke</kwd>
                <kwd>exercise</kwd>
              </kwd-group>
              <funding-group specific-use="FundRef">
                <award-group id="award1-17474930221129982">
                  <funding-source id="funding1-17474930221129982">
                    <institution-wrap>
                      <institution>Michael Smith Foundation for Health Research Scholar
Award</institution>
                      <institution-id/>
                    </institution-wrap>
                  </funding-source>
                  <award-id rid="funding1-17474930221129982">BMS</award-id>
                </award-group>
                <award-group id="award2-17474930221129982">
                  <funding-source id="funding2-17474930221129982">
                    <institution-wrap>
                      <institution>Michael Smith Foundation for Health Research</institution>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100000245</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id rid="funding2-17474930221129982">Fellowship SP</award-id>
                </award-group>
                <award-group id="award3-17474930221129982">
                  <funding-source id="funding3-17474930221129982">
                    <institution-wrap>
                      <institution>Canadian Institutes of Health Research</institution>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100000024</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id rid="funding3-17474930221129982">Fellowship SP</award-id>
                </award-group>
                <award-group id="award4-17474930221129982">
                  <funding-source id="funding4-17474930221129982">
                    <institution-wrap>
                      <institution>Canadian Institutes of Health Research</institution>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100000024</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id rid="funding4-17474930221129982">Operating Grant FDN 143340
JJE</award-id>
                </award-group>
                <award-group id="award5-17474930221129982">
                  <funding-source id="funding5-17474930221129982">
                    <institution-wrap>
                      <institution>Canada Research Chair Program</institution>
                      <institution-id/>
                    </institution-wrap>
                  </funding-source>
                  <award-id rid="funding5-17474930221129982">JJE</award-id>
                </award-group>
                <award-group id="award6-17474930221129982">
                  <funding-source id="funding6-17474930221129982">
                    <institution-wrap>
                      <institution>Heart and Stroke Foundation Canadian Partnership for Stroke
Recovery Operating Grant</institution>
                      <institution-id/>
                    </institution-wrap>
                  </funding-source>
                  <award-id rid="funding6-17474930221129982">JJE</award-id>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>typesetter</meta-name>
                  <meta-value>ts1</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="section6-17474930221129982">
              <title>Introduction and rationale</title>
              <p>The ability to regain walking independence is one of the most frequently cited goals
of people living with stroke.<sup><xref rid="bibr1-17474930221129982" ref-type="bibr">1</xref></sup> Despite many trials,
meta-analyses, and guidelines<sup><xref rid="bibr2-17474930221129982" ref-type="bibr">2</xref><xref rid="bibr3-17474930221129982" ref-type="bibr"/>–<xref rid="bibr4-17474930221129982" ref-type="bibr">4</xref></sup> over the last decade which show
that structured, progressive exercise is safe and effective for individuals
post-stroke, activity continues to be very low.<sup><xref rid="bibr5-17474930221129982" ref-type="bibr">5</xref>,<xref rid="bibr6-17474930221129982" ref-type="bibr">6</xref></sup> In our recent study—six sites
over three provinces between 2014 and 2018 (n = 75)—participants with stroke did a
small amount of walking (averaged 580 steps) in their usual daily physical therapy
sessions.<sup><xref rid="bibr7-17474930221129982" ref-type="bibr">7</xref></sup> We then found that a structured, progressive protocol integrated
with typical daily physical therapy resulted in substantially greater walking
activity during therapy sessions and improved walking (60 m on a 6-Minute Walk Test
(6MWT)) and quality of life measures over usual care with walking gains maintained
for 1 year after stroke.<sup><xref rid="bibr7-17474930221129982" ref-type="bibr">7</xref></sup> One therapist on the unit was assigned to deliver the
intervention and progressed the intensity of exercise through heart rate and step
counters worn by the participants with stroke during therapy.</p>
              <p>To have the greatest impact, our next step is to undertake an implementation trial to
improve practice across stroke units where we enable the entire unit (rather than
one assigned therapist) to use the protocol as part of standard of care. This
implementation trial is also informed by lessons learned from our stakeholders where
we formally engaged with 15 clinicians<sup><xref rid="bibr8-17474930221129982" ref-type="bibr">8</xref></sup> and 10 participants with
stroke<sup><xref rid="bibr9-17474930221129982" ref-type="bibr">9</xref></sup> about their experience with the structured, progressive exercise
protocol.</p>
              <p>The aim is to determine what is the effect of introducing structured, progressive
exercise (termed Walk ’n Watch protocol) to the standard of care on the primary
outcome of walking in adult participants with stroke over the hospital inpatient
rehabilitation period? We hypothesize that the Walk ’n Watch protocol, compared to
Usual Care, will result in improvements of walking endurance in participants with
stroke over the inpatient rehabilitation period. We also hypothesize the
improvements in our secondary outcomes, which include quality of life. Changes in
standard care will be undertaken through developing local expertise through hands-on
workshops with physical therapists and rehabilitation assistants to integrate the
Walk ’n Watch protocol within their therapy.</p>
            </sec>
            <sec sec-type="methods" id="section7-17474930221129982">
              <title>Methods</title>
              <sec id="section8-17474930221129982">
                <title>Design</title>
                <p>This national, multisite-randomized controlled clinical trial will use a
cross-sectional, stepped-wedge cluster design. This design was chosen following
a small efficacy trial<sup><xref rid="bibr2-17474930221129982" ref-type="bibr">2</xref></sup> to facilitate implementation of the intervention across
Canada and to prevent contamination and disappointment effects in hospitals not
randomized to the intervention. The 12 inpatient hospital sites can be found on
the trial registry (<ext-link xlink:href="http://www.ClinicalTrials.gov" ext-link-type="uri">www.ClinicalTrials.gov</ext-link>
ID: NCT04238260).</p>
                <p>The coordinating center (the Rehabilitation Research Program) will prepare the
protocol and study documents; organize meetings, data entry, and analysis;
disseminate results through publications and presentations; and liaise with site
coordinators. The coordinating center will have access to final de-identified
data sets, which will be collected from each site throughout the study, inputted
into master sheets and double-checked. Individual sites will retain access to
site-specific data. The steering committee (authors of this article) will
provide agreement of the final protocol and review any adverse events, study
progress, and any changes of the study that will be updated on the trial
registry. Authorship guidelines will follow the recommendations of the
International Committee of Medical Journal Editors. No professional writers will
be used.</p>
              </sec>
              <sec id="section9-17474930221129982">
                <title>Patient population</title>
                <p>Broad inclusion criteria will be purposely implemented to capture real-world
caseloads in stroke rehabilitation units. To be included, participants will be
adults, will have a confirmed stroke that occurred within 12 weeks of rehab
admission, admitted for inpatient stroke rehabilitation for walking, medically
stable (e.g. stable cardiovascular condition, no active cancer), able to walk
five steps with a maximum of one person helping, and able to understand and
follow instructions. Study coordinators will be knowledgeable in supportive
conversations for people with aphasia, and we will provide the option to have a
caregiver present for consent. The aim is to recruit individuals as soon as they
are admitted to the inpatient stroke rehabilitation unit. Participants will be
excluded if they have another neurological condition, enrolled in another
rehabilitation study, or expected to receive less than 2 weeks of inpatient
physical therapy. If a potential participant is enrolled in a trial during acute
care, we will communicate with the trialist about their study to ensure outcomes
for each trial will not be affected prior to enrolling. Each site’s study
coordinator will obtain consent and enroll participants. Participants will be
aware they are receiving standard care for each phase of the study and will only
be enrolled in one phase.</p>
              </sec>
              <sec id="section10-17474930221129982">
                <title>Randomization</title>
                <p>Randomization schedule details are given in <xref rid="fig1-17474930221129982" ref-type="fig">Figure 1</xref>. Prior to the start of the
trial, three sites were randomly allocated to each of the four transition
sequences by the trial statistician using statistical software. To mitigate the
risk of loss to power due to expected large variation in enrolments across
sites, randomizations were stratified on expected enrolments (four largest sites
in stratum 1, remaining eight sites in stratum 2).<sup><xref rid="bibr10-17474930221129982" ref-type="bibr">10</xref></sup> Each site will be
notified of the site’s transition date after recruiting their first participant
and will not be notified of the transition dates of other sites.</p>
                <fig position="float" id="fig1-17474930221129982">
                  <label>Figure 1.</label>
                  <caption>
                    <p>Randomization schedule.</p>
                  </caption>
                  <graphic xlink:href="10.1177_17474930221129982-fig1" position="float"/>
                </fig>
              </sec>
              <sec id="section11-17474930221129982">
                <title>Physical therapy</title>
                <p>Specific exercises and treatments will be up to the discretion of the treating
therapist. Any discontinuation of treatment will be determined by the site
rehabilitation department as per usual rehabilitation planning. Study staff will
document any circumstances leading to discontinuation.</p>
                <sec id="section12-17474930221129982">
                  <title>Phase 1</title>
                  <p>Phase 1 is the care that physical therapists typically provide their
participants with stroke. No changes to treatment are made during this
phase.</p>
                </sec>
                <sec id="section13-17474930221129982">
                  <title>The 2-week transition period</title>
                  <p>Training for the Walk ’n Watch protocol will be undertaken with hands-on
workshops with physical therapists and rehabilitation assistants in the
2-week transition period between phase 1 and phase 2 (<xref rid="fig1-17474930221129982" ref-type="fig">Figure 1</xref>). During this time,
recruitment is paused to avoid contamination. Assessors are not made aware
of the timing of the switch from phase 1 to phase 2.</p>
                </sec>
                <sec id="section14-17474930221129982">
                  <title>Phase 2</title>
                  <p>To avoid contamination, a brief outline of the protocol is summarized here,
and an in-depth description will be provided at the end of the trial using
the TIDeiR framework. The Walk ’n Watch protocol focuses on completing a
minimum of 30 min of weight-bearing, walking-related activities that
progressively increase in intensity. The protocol will aim to achieve
individualized, progressive step targets based on a participant’s walking
distance at baseline (<xref rid="table1-17474930221129982" ref-type="table">Table 1</xref>) and work toward 40–60% heart rate reserve for 30 min, 5
days a week.</p>
                  <table-wrap position="float" id="table1-17474930221129982">
                    <label>Table 1.</label>
                    <caption>
                      <p>Progression of Walk ’n Watch protocol.</p>
                    </caption>
                    <alternatives>
                      <graphic xlink:href="10.1177_17474930221129982-table1" position="float"/>
                      <table frame="hsides" rules="groups">
                        <colgroup span="1">
                          <col align="left" span="1"/>
                          <col align="char" char="." span="1"/>
                          <col align="char" char="." span="1"/>
                          <col align="char" char="." span="1"/>
                        </colgroup>
                        <thead>
                          <tr>
                            <th align="left" rowspan="1" colspan="1">6-Minute Walk Test<break/>Distance at
baseline</th>
                            <th align="left" rowspan="1" colspan="1">Week 1<break/>Step Goal</th>
                            <th align="left" rowspan="1" colspan="1">Week 2<break/>Step Goal</th>
                            <th align="left" rowspan="1" colspan="1">Week 4<break/>Step Goal</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td rowspan="1" colspan="1">100 m or less</td>
                            <td rowspan="1" colspan="1">1000</td>
                            <td rowspan="1" colspan="1">1500</td>
                            <td rowspan="1" colspan="1">2000</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Between 100 and 200 m</td>
                            <td rowspan="1" colspan="1">2000</td>
                            <td rowspan="1" colspan="1">2500</td>
                            <td rowspan="1" colspan="1">3000</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">200 m or more</td>
                            <td rowspan="1" colspan="1">3000</td>
                            <td rowspan="1" colspan="1">3500</td>
                            <td rowspan="1" colspan="1">4000</td>
                          </tr>
                        </tbody>
                      </table>
                    </alternatives>
                  </table-wrap>
                  <p>Focus will be on walking and functional weight-bearing activities, to work
toward meeting national stroke guidelines.<sup><xref rid="bibr3-17474930221129982" ref-type="bibr">3</xref>,<xref rid="bibr4-17474930221129982" ref-type="bibr">4</xref></sup> The inpatient unit will
be provided with an activity tracking watch that clinicians will use to
monitor heart rate (Garmin Forerunner 235, Garmin Ltd., USA) and a step
counter to monitor the number of steps (Fitbit Inspire, Alphabet Inc., USA,
placed on the ankle)<sup><xref rid="bibr11-17474930221129982" ref-type="bibr">11</xref></sup> during physical
therapy sessions. All eligible participants with stroke admitted to the unit
will receive the Walk ’n Watch protocol as it will be considered standard
care, even if they have not consented to the study. Participants with stroke
who consent to the study will also receive their own activity tracking
watch.</p>
                </sec>
              </sec>
              <sec id="section15-17474930221129982">
                <title>Outcome measures</title>
                <p>Physical and cognitive abilities, physical activity, and quality of life will be
measured at three time points—baseline (T1), 4 weeks later (T2), and 12 months
post-stroke (T3)—by a trained assessor blinded to time of the switch-over to the
Walk ’n Watch phase (<xref rid="fig2-17474930221129982" ref-type="fig">Figure
2</xref>). We will also have two telephone calls at 6 and 9 months
post-stroke, to ask about any changes in health.</p>
                <fig position="float" id="fig2-17474930221129982">
                  <label>Figure 2.</label>
                  <caption>
                    <p>Overview of study procedures during phases 1 and 2.</p>
                  </caption>
                  <graphic xlink:href="10.1177_17474930221129982-fig2" position="float"/>
                </fig>
                <p>The primary outcome will be the change in walking endurance (6MWT) from T1 to T2.
Secondary outcome measures and assessment timing are given in <xref rid="table2-17474930221129982" ref-type="table">Table 2</xref>.</p>
                <table-wrap position="float" id="table2-17474930221129982">
                  <label>Table 2.</label>
                  <caption>
                    <p>Overview of study outcome measures.</p>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="10.1177_17474930221129982-table2" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1">Baseline (T1)</th>
                          <th align="left" rowspan="1" colspan="1">4-weeks (T2)</th>
                          <th align="left" rowspan="1" colspan="1">12-months (T3)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td colspan="4" rowspan="1">Primary outcome measure</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> 6-Minute Walk Test (6MWT)</td>
                          <td rowspan="1" colspan="1">✔</td>
                          <td rowspan="1" colspan="1">✔</td>
                          <td rowspan="1" colspan="1">✔</td>
                        </tr>
                        <tr>
                          <td colspan="4" rowspan="1">Secondary outcome measures</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Resting blood pressure and heart rate</td>
                          <td rowspan="1" colspan="1">✔</td>
                          <td rowspan="1" colspan="1">✔</td>
                          <td rowspan="1" colspan="1">✔</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> EQ-5D-5L</td>
                          <td rowspan="1" colspan="1">✔</td>
                          <td rowspan="1" colspan="1">✔</td>
                          <td rowspan="1" colspan="1">✔</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Montreal cognitive assessment</td>
                          <td rowspan="1" colspan="1">✔</td>
                          <td rowspan="1" colspan="1">✔</td>
                          <td rowspan="1" colspan="1">✔</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Short physical performance battery</td>
                          <td rowspan="1" colspan="1">✔</td>
                          <td rowspan="1" colspan="1">✔</td>
                          <td rowspan="1" colspan="1">✔</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Patient health questionnaire-9</td>
                          <td rowspan="1" colspan="1">✔</td>
                          <td rowspan="1" colspan="1">✔</td>
                          <td rowspan="1" colspan="1">✔</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Modified Rankin scale</td>
                          <td rowspan="1" colspan="1">✔</td>
                          <td rowspan="1" colspan="1">✔</td>
                          <td rowspan="1" colspan="1">✔</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Physical activity scale for the elderly</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">✔</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> 3-day daily step count<sup><xref rid="table-fn1-17474930221129982" ref-type="table-fn">a</xref></sup></td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">✔</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="table-fn1-17474930221129982">
                      <label>a</label>
                      <p>Measured using the StepWatch™ (Modus Health, USA).</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Further planned evaluation of intervention fidelity and protocol adherence
(developed using the Normalization Process Theory) is through: (1) weekly
meetings with the unit therapists (led by the site coordinator) documenting
barriers and facilitators of the implementation of Walk ’n Watch, (2)
qualitative interviews with a smaller set of site therapists and rehabilitation
assistants, and (3) survey of all therapists, rehabilitation assistants, and
site managers who participated.</p>
              </sec>
              <sec id="section16-17474930221129982">
                <title>Sample size</title>
                <p>The planned total sample size is 195, allowing for a 20% dropout. The power
calculations were performed using the R package, “swCRTdesign.”<sup><xref rid="bibr12-17474930221129982" ref-type="bibr">12</xref></sup> The input
values were derived from a mixed-effects model analysis of the pilot trial
data,<sup><xref rid="bibr7-17474930221129982" ref-type="bibr">7</xref></sup> in which the treatment effect was a 60-m improvement in the
6MWT, and the effective (adjusted for covariates including baseline 6MWT) within
group standard deviation was 90 m. The intracluster correlation coefficient
(ICC) was essentially zero, but we used a value of 0.01 in the power calculation
to be conservative. Based on these input values and an assumed cluster
auto-correlation coefficient (CAC) of 0.8, a design with a total of 12 clusters,
and 3 clusters transitioning at each step, requires 13 participants per cluster,
or 156 participants in total, to achieve 80% power with a Type I error rate of
5%. (Note that this calculation is insensitive to the assumed CAC value due to
the low ICC value.) Allowing for 20% dropout increases the sample size to
195.</p>
              </sec>
              <sec id="section17-17474930221129982">
                <title>Statistical analysis</title>
                <p>The primary analysis will compare, using intent-to-treat, the change in 6MWT for
the Walk ’n Watch protocol versus Usual Care using a linear mixed-effects model.
A random intercept for site will be included to account for clustering. The
model will adjust for the calendar time as a continuous variable (to account for
the staggered start dates across sites) instead of periods of time. Other
adjustment variables will include the baseline 6MWT. A detailed Statistical
Analysis Plan document that identifies the full list of adjustment variables
will be finalized prior to database lock. Adjustment for time effects in the
stepped-wedge design induces large increases in the treatment effect standard
error. As a supplementary analysis to explore how inferences might differ if
expert judgments regarding the time effect are utilized, we will also conduct a
Bayesian analysis to increase precision by incorporating an informative prior on
the time effect that will be elicited from stroke rehabilitation
experts.<sup><xref rid="bibr13-17474930221129982" ref-type="bibr">13</xref></sup> Secondary outcomes will be analyzed using mixed-effects
models similar to that used for the primary outcome. Planned exploratory
subgroup analyses will assess the impact of Walk ’n Watch by sex and age.</p>
              </sec>
              <sec id="section18-17474930221129982">
                <title>Safety and adverse event monitoring</title>
                <p>Three physiatrists form the Safety Monitoring Board for this implementation
study. Major safety concerns have already been tested in the pilot trial, and no
serious adverse events occurred related to the protocol.<sup><xref rid="bibr7-17474930221129982" ref-type="bibr">7</xref></sup> All sites
will monitor and report any serious adverse events that occur throughout the
study. As recommended by the Canadian Stroke Aerobics Guidelines, the 6MWT will
be used as a safety screen prior to commencing physical therapy.</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="section19-17474930221129982">
              <title>Discussion and summary</title>
              <p>Clinical practice guidelines, studies in the literature, and our own studies support
structured, progressive protocols for improving walking after stroke. Implementing a
stepped-wedge design enables the protocol to be tested under real-world conditions,
involving all clinicians on the unit, and results in all sites and all clinicians on
the unit to ultimately gain expertise in delivering the protocol to facilitate best
practice.</p>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn fn-type="COI-statement">
                <p>The author(s) declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</p>
              </fn>
              <fn fn-type="financial-disclosure">
                <p><bold>Funding:</bold> The author(s) disclosed receipt of the following financial support for the
research, authorship, and/or publication of this article: The study was
supported by Canadian Institutes of Health Research (Operating Grant FDN 143340
(J.J.E.); Fellowship (S.P.)), Canada Research Chair Program (J.J.E.), Heart and
Stroke Foundation Canadian Partnership for Stroke Recovery Operating Grant
(J.J.E.), Michael Smith Foundation for Health Research Fellowship (S.P.), and
Michael Smith Foundation for Health Research Scholar Award (B.M.S.). No funders
contributed to any aspect of the study.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Ethical approval:</bold> Ethics approval already obtained from each site.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Registration:</bold><ext-link xlink:href="http://www.ClinicalTrials.gov" ext-link-type="uri">www.ClinicalTrials.gov</ext-link> ID: NCT04238260</p>
              </fn>
              <fn fn-type="other">
                <p><bold>ORCID iDs:</bold> Mark T Bayley <inline-graphic xlink:href="10.1177_17474930221129982-img1.jpg"/>
<ext-link xlink:href="https://orcid.org/0000-0001-7860-9463" ext-link-type="uri">https://orcid.org/0000-0001-7860-9463</ext-link></p>
                <p>Janice J Eng <inline-graphic xlink:href="10.1177_17474930221129982-img1.jpg"/>
<ext-link xlink:href="https://orcid.org/0000-0002-2093-0788" ext-link-type="uri">https://orcid.org/0000-0002-2093-0788</ext-link></p>
              </fn>
              <fn fn-type="other">
                <p><bold>Availability of data and materials:</bold> The datasets will be available 12 months after publication of the trial at UBC
Dataverse, a publicly accessible data repository.</p>
              </fn>
            </fn-group>
            <ref-list>
              <title>References</title>
              <ref id="bibr1-17474930221129982">
                <label>1.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollock</surname><given-names>A</given-names></name><name><surname>St George</surname><given-names>B</given-names></name><name><surname>Fenton</surname><given-names>M</given-names></name><name><surname>Firkins</surname><given-names>L</given-names></name></person-group>. <article-title>Top 10 research priorities relating to life
after stroke—consensus from stroke survivors, caregivers, and health
professionals</article-title>. <source>Int J Stroke</source><year>2014</year>; <volume>9</volume>:
<fpage>313</fpage>–<lpage>320</lpage>.<pub-id pub-id-type="pmid">23227818</pub-id></mixed-citation>
              </ref>
              <ref id="bibr2-17474930221129982">
                <label>2.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winstein</surname><given-names>CJ</given-names></name><name><surname>Stein</surname><given-names>J</given-names></name><name><surname>Arena</surname><given-names>R</given-names></name></person-group>, <etal>et al</etal><article-title>Guidelines for adult stroke rehabilitation and recovery: a
guideline for healthcare professionals from the American Heart
Association/American Stroke Association</article-title>.
<source>Stroke</source><year>2016</year>; <volume>47</volume>: e98–e169.</mixed-citation>
              </ref>
              <ref id="bibr3-17474930221129982">
                <label>3.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billinger</surname><given-names>SA</given-names></name><name><surname>Arena</surname><given-names>R</given-names></name><name><surname>Bernhardt</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal><article-title>Physical activity and exercise recommendations for stroke
survivors: a statement for healthcare professionals from the American Heart
Association/American Stroke Association</article-title>.
<source>Stroke</source><year>2014</year>; <volume>45</volume>:
<fpage>2532</fpage>–<lpage>2553</lpage>.<pub-id pub-id-type="pmid">24846875</pub-id></mixed-citation>
              </ref>
              <ref id="bibr4-17474930221129982">
                <label>4.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacKay-Lyons</surname><given-names>M</given-names></name><name><surname>Billinger</surname><given-names>SA</given-names></name></person-group>, <etal>et al</etal><article-title>Aerobic exercise recommendations to optimize best practices in
care after stroke: AEROBICS 2019 update</article-title>. <source>Phys
Ther</source><year>2020</year>; <volume>23100</volume>:
<fpage>149</fpage>–<lpage>156</lpage>.</mixed-citation>
              </ref>
              <ref id="bibr5-17474930221129982">
                <label>5.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rand</surname><given-names>D</given-names></name><name><surname>Eng</surname><given-names>JJ</given-names></name></person-group>. <article-title>Disparity between functional recovery and daily
use of the upper and lower extremities during subacute stroke
rehabilitation</article-title>. <source>Neurorehabil Neural Repair</source><year>2012</year>; <volume>26</volume>:
<fpage>76</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">21693771</pub-id></mixed-citation>
              </ref>
              <ref id="bibr6-17474930221129982">
                <label>6.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>CE</given-names></name><name><surname>Macdonald</surname><given-names>JR</given-names></name><name><surname>Reisman</surname><given-names>DS</given-names></name></person-group>, <etal>et al</etal><article-title>Observation of amounts of movement practice provided during
stroke rehabilitation</article-title>. <source>Arch Phys Med
Rehabil</source><year>2009</year>; <volume>90</volume>:
<fpage>1692</fpage>–<lpage>1698</lpage>.<pub-id pub-id-type="pmid">19801058</pub-id></mixed-citation>
              </ref>
              <ref id="bibr7-17474930221129982">
                <label>7.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klassen</surname><given-names>TD</given-names></name><name><surname>Dukelow</surname><given-names>SP</given-names></name><name><surname>Bayley</surname><given-names>MT</given-names></name></person-group>, <etal>et al</etal><article-title>Higher doses improve walking recovery during stroke inpatient
rehabilitation</article-title>. <source>Stroke</source><year>2020</year>; <volume>51</volume>:
<fpage>2639</fpage>–<lpage>2648</lpage>.<pub-id pub-id-type="pmid">32811378</pub-id></mixed-citation>
              </ref>
              <ref id="bibr8-17474930221129982">
                <label>8.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connell</surname><given-names>LA</given-names></name><name><surname>Klassen</surname><given-names>TK</given-names></name><name><surname>Janssen</surname><given-names>J</given-names></name><name><surname>Thetford</surname><given-names>C</given-names></name><name><surname>Eng</surname><given-names>JJ</given-names></name></person-group>. <article-title>Delivering intensive rehabilitation in stroke:
factors influencing implementation</article-title>. <source>Phys
Ther</source><year>2018</year>; <volume>98</volume>:
<fpage>243</fpage>–<lpage>250</lpage>.<pub-id pub-id-type="pmid">29415282</pub-id></mixed-citation>
              </ref>
              <ref id="bibr9-17474930221129982">
                <label>9.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janssen</surname><given-names>J</given-names></name><name><surname>Klassen</surname><given-names>TD</given-names></name><name><surname>Connell</surname><given-names>LA</given-names></name><name><surname>Eng</surname><given-names>JJ</given-names></name></person-group>. <article-title>Factors influencing the delivery of intensive
rehabilitation in stroke: patient perceptions versus rehabilitation
therapist perceptions</article-title>. <source>Phys Ther</source><year>2020</year>; <volume>7100</volume>:
<fpage>307</fpage>–<lpage>316</lpage>.</mixed-citation>
              </ref>
              <ref id="bibr10-17474930221129982">
                <label>10.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouyang</surname><given-names>Y</given-names></name><name><surname>Karim</surname><given-names>ME</given-names></name><name><surname>Gustafson</surname><given-names>P</given-names></name><name><surname>Eng</surname><given-names>JJ</given-names></name></person-group>. <article-title>Explaining the variation in the attained power
of a stepped-wedge trial with unequal cluster sizes, BMC medical research
methodology</article-title><year>2020</year>; <volume>20</volume>: <fpage>166</fpage>.</mixed-citation>
              </ref>
              <ref id="bibr11-17474930221129982">
                <label>11.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klassen</surname><given-names>TD</given-names></name><name><surname>Simpson</surname><given-names>LA</given-names></name><name><surname>Lim</surname><given-names>SB</given-names></name></person-group>, <etal>et al</etal><article-title>“Stepping up” activity poststroke: ankle-positioned accelerometer
can accurately record steps during slow walking</article-title>.
<source>Phys Ther</source><year>2016</year>; <volume>96</volume>:
<fpage>355</fpage>–<lpage>360</lpage>.<pub-id pub-id-type="pmid">26251478</pub-id></mixed-citation>
              </ref>
              <ref id="bibr12-17474930221129982">
                <label>12.</label>
                <mixed-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>J</given-names></name><name><surname>Hakhu</surname><given-names>NR</given-names></name><name><surname>Voldal</surname><given-names>E</given-names></name><name><surname>Xia</surname><given-names>F</given-names></name></person-group>. <article-title>swCRTdesign: stepped wedge cluster randomized
trial (SW CRT) design. R package version 3.2</article-title>, <ext-link xlink:href="https://CRAN.R-project.org/package=swCRTdesign" ext-link-type="uri">https://CRAN.R-project.org/package=swCRTdesign</ext-link>
(<year>2022</year>, <comment>accessed 1 March
2022</comment>).</mixed-citation>
              </ref>
              <ref id="bibr13-17474930221129982">
                <label>13.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>D</given-names></name><name><surname>Ouyang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Wong</surname><given-names>H</given-names></name></person-group>. <article-title>Improving efficiency in the stepped-wedge trial
design via Bayesian modeling with an informative prior for the time
effects</article-title>. <source>Clin Trials</source><year>2021</year>; <volume>18</volume>:
<fpage>295</fpage>–<lpage>302</lpage>.<pub-id pub-id-type="pmid">33813906</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
